RTC-30
CAS: 1423077-95-5
Ref. 3D-YGC07795
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Información del producto
RTC-30 is a tricyclic dibenzazepine compound that has been reengineered to have increased potency and selectivity. RTC-30 inhibits the enzyme phosphatase, which is involved in cancer cell proliferation. The pharmacological properties of RTC-30 were assessed using assays for anti-cancer activity in xenografts. In these studies, tumor size was reduced by about 50% at the end of the study, compared to untreated control animals. RTC-30 also inhibited tumor growth in mice with implanted human prostate cancer cells, inhibiting both tumor growth and metastasis.
Propiedades químicas
Consulta técnica sobre: 3D-YGC07795 RTC-30
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.